Investors

Overview

Corporate Profile

Forward Pharma is a biotechnology company focused on the immunomodulatory compound dimethyl fumarate and derivatives, for applications as a pharmaceutical drug product to treat immune disorders such as multiple sclerosis and psoriasis.

Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark, in the heart of Medicon Valley. Since 2007 we have also operated out of a subsidiary, Forward Pharma GmbH, in Leipzig, Germany, and since August 2014 out of a subsidiary in the United States, Forward Pharma USA, LLC.


Most Recent Presentation
Download Documentation Credit Suisse Healthcare Conference

Stock Information
FWP (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Financial Status IndicatorC
Price$17.51
Change (%) Stock is Down 0.43 (2.40%)
Volume1,939
Data as of 12/02/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock chart for: FWP.OQ.  Currently trading at $17.51 with a 52 week high of $25.74 and a 52 week low of $11.22.

Recent NewsMore >>
DateTitle 
11/29/16Forward Pharma Reports Third Quarter 2016 Financial and Operational Results
COPENHAGEN, Denmark, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward” or the “Company”), today reported financial results for the third quarter ended September 30, 2016.  Net loss for the third quarter ended September 30, 2016 was $11.0 million, or $0.23 per basic share versus a net loss of $15.8 million, or $0.34 per basic share for the third quarter of 2015.  On a non-GAAP basis, after removing the effect of non-cash income and expense items, our third qua... 
Printer Friendly Version
11/02/16Forward Pharma CFO to Participate in the Credit Suisse Annual Healthcare Conference in November
COPENHAGEN, Denmark, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl fumarate) for the treatment of inflammatory and neurological indications, today announced that Joel Sendek, the Company’s Chief Financial Officer, will participate in the following conference:    Credit Suisse Annual Healthcare Conference to be held at The Phoenician in Scottsdale, Arizona.  Mr. Sendek ... 
Printer Friendly Version
09/06/16Forward Pharma CFO to Participate in Three Investor Conferences in September
COPENHAGEN, Denmark, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl fumarate) for the treatment of inflammatory and neurological indications, today announced that Joel Sendek, the Company’s Chief Financial Officer, will participate in the following conferences: Wells Fargo Securities Healthcare Conference to be held at the Westin Boston Waterfront in Boston, Mas... 
Printer Friendly Version
09/01/16Forward Pharma Reports Second Quarter 2016 Financial and Operational Results
COPENHAGEN, Denmark, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward” or the “Company”), today reported financial results for the second quarter ended June 30, 2016.  Net loss for the second quarter ended June 30, 2016 was $15.1 million, or $0.32 per basic share versus a net loss of $17.7 million, or $0.38 per basic share for second quarter of 2015.  On a non-GAAP basis, after removing the effect of non-cash income and expense items, our second quarter net ... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
12/07/16
through
12/08/16
Forward Pharma A/S at Citigroup Healthcare Conference
LocationNew York, NY
02/15/17
Forward Pharma A/S at Leerink Partners Healthcare Conference
LocationNew York, NY
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Forward Pharma A/S posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources